Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 741.29

-0.7%

Dec 12 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Madharry who wrote (792)	4/23/2003 11:35:30 AM
From: keokalani'nui	Read Replies (2) of 3559

This board could probably use a little more recovery time before talking about regn valuation. Regn's lead trap, IL-1, is fabulous--so far--and it is a better target--probably--than tnf for RA. I'd be willing to speculate that il-4/13 trap will be similarly promising. If you write off axokine, does that make the investment "compelling"? Interesting, certainly....and clearly there's enough umph to recover losses in the future if you are patient. Regrettably, as Miljenko pointed out at the time, taking on the CV debt was a big mistake. Because of it, I think the stock could easily see the $5's first. Wilder

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next